Complete, long-term remission of refractory idiopathic cold haemagglutinin disease after Mabthera

被引：12
作者：
Gharib, M [1 ]
Poynton, C [1 ]
机构：
[1] Univ Wales Coll Med, Dept Haematol, Cardiff CF4 4XN, S Glam, Wales
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2002年 / 117卷 / 01期
关键词：
Mabthera; anti CD20; monoclonal; cold haemagglutinin disease; haemolysis;
D O I：
10.1046/j.1365-2141.2002.3406_2.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：248 / 249
页数：2
相关论文
共 6 条
  • [1] Rituximab: A very efficient therapy in cold agglutinins and refractory autoimmune haematolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma.
    Bauduer, F
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (04) : 1085 - 1086
  • [2] No response to cladribine in five patients with chronic cold agglutinin disease
    Berentsen, S
    Tjonnfjord, GE
    Shammas, FV
    Bergheim, J
    Hammerstrom, J
    Langholm, R
    Ulvestad, E
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (01) : 88 - 90
  • [3] Remission of severe cold agglutinin disease after Rituximab therapy
    Layios, N
    Van den Neste, E
    Jost, E
    Deneys, V
    Scheiff, JM
    Ferrant, A
    [J]. LEUKEMIA, 2001, 15 (01) : 187 - 188
  • [4] Rituxan in the treatment of cold agglutinin disease
    Lee, EJ
    Kueck, B
    [J]. BLOOD, 1998, 92 (09) : 3490 - 3491
  • [5] Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program
    McLaughlin, P
    Grillo-López, AJ
    Link, BK
    Levy, R
    Czuczman, MS
    Williams, ME
    Heyman, MR
    Bence-Bruckler, I
    White, CA
    Cabanillas, F
    Jain, V
    Ho, AD
    Lister, J
    Wey, K
    Shen, D
    Dallaire, BK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2825 - 2833
  • [6] ROSSE W, 1997, HEMATOLOGY 1997, P92
1